Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data.

Whiting P, Birnie K, Sterne JAC, Jameson C, Skinner R, Phillips B; Cystatin C in Childhood Cancer Collaboration Group.

Support Care Cancer. 2017 Dec 6. doi: 10.1007/s00520-017-4002-3. [Epub ahead of print]

PMID:
29209836
2.

Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.

Giganti F, Gambarota G, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Whitcher B, Castro-Santamaria R, Emberton M, Allen C, Kirkham A.

J Magn Reson Imaging. 2017 Nov 14. doi: 10.1002/jmri.25891. [Epub ahead of print]

PMID:
29135073
3.

The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer.

Grey A, Scott R, Charman S, van der Meulen J, Frinking P, Acher P, Liyanage S, Madaan S, Constantinescu G, Shah B, Graves CB, Freeman A, Jameson C, Ramachandran N, Emberton M, Arya M, Ahmed HU.

Contemp Clin Trials. 2017 Nov 3. pii: S1551-7144(17)30073-3. doi: 10.1016/j.cct.2017.10.011. [Epub ahead of print]

PMID:
29108869
4.

Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma.

Albersen M, Parnham A, Joniau S, Sahdev V, Christodoulidou M, Castiglione F, Nigam R, Malone P, Freeman A, Jameson C, Minhas S, Ralph DJ, Muneer A.

Urol Oncol. 2017 Sep 4. pii: S1078-1439(17)30387-3. doi: 10.1016/j.urolonc.2017.07.025. [Epub ahead of print]

PMID:
28882673
5.

The Composition of the Mobile Phase Affects the Dynamic Chiral Recognition of Drug Molecules by the Chiral Stationary Phase.

Zhao B, Oroskar PA, Wang X, House D, Oroskar A, Oroskar A, Jameson C, Murad S.

Langmuir. 2017 Oct 24;33(42):11246-11256. doi: 10.1021/acs.langmuir.7b02337. Epub 2017 Aug 29.

PMID:
28826215
6.

The diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients.

Kravvas G, Shim TN, Doiron PR, Freeman A, Jameson C, Minhas S, Muneer A, Bunker CB.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):91-95. doi: 10.1111/jdv.14488. Epub 2017 Aug 16.

PMID:
28750140
7.

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.

Giganti F, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Gambarota G, Whitcher B, Castro R, Emberton M, Allen C, Kirkham A.

Eur Radiol. 2017 Nov;27(11):4767-4774. doi: 10.1007/s00330-017-4858-0. Epub 2017 May 18.

8.

Feasibility cluster randomised controlled trial of a within-consultation intervention to reduce antibiotic prescribing for children presenting to primary care with acute respiratory tract infection and cough.

Blair PS, Turnbull S, Ingram J, Redmond N, Lucas PJ, Cabral C, Hollinghurst S, Dixon P, Peters T, Horwood J, Little P, Francis NA, Gilbertson A, Jameson C, Hay AD.

BMJ Open. 2017 May 9;7(5):e014506. doi: 10.1136/bmjopen-2016-014506.

9.

Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.

Bass EJ, Donaldson IA, Freeman A, Jameson C, Punwani S, Moore C, Arya M, Emberton M, Ahmed HU.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):311-317. doi: 10.1038/pcan.2017.13. Epub 2017 May 9.

PMID:
28485391
10.

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy.

Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Freeman A, Gelister J, Hawkes D, Hu Y, Jameson C, McCartan N, Moore CM, Punwani S, Ramachandran N, van der Meulen J, Emberton M, Ahmed HU.

Br J Cancer. 2017 Apr 25;116(9):1159-1165. doi: 10.1038/bjc.2017.57. Epub 2017 Mar 28.

PMID:
28350785
11.

UroMark-a urinary biomarker assay for the detection of bladder cancer.

Feber A, Dhami P, Dong L, de Winter P, Tan WS, Martínez-Fernández M, Paul DS, Hynes-Allen A, Rezaee S, Gurung P, Rodney S, Mehmood A, Villacampa F, de la Rosa F, Jameson C, Cheng KK, Zeegers MP, Bryan RT, James ND, Paramio JM, Freeman A, Beck S, Kelly JD.

Clin Epigenetics. 2017 Jan 31;9:8. doi: 10.1186/s13148-016-0303-5. eCollection 2017.

12.

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial.

Moore CM, Robertson NL, Jichi F, Damola A, Ambler G, Giganti F, Ridout AJ, Bott SR, Winkler M, Ahmed HU, Arya M, Mitra AV, McCartan N, Freeman A, Jameson C, Castro R, Gambarota G, Whitcher BJ, Allen C, Kirkham A, Emberton M.

J Urol. 2017 Apr;197(4):1006-1013. doi: 10.1016/j.juro.2016.11.090. Epub 2016 Nov 19.

PMID:
27871928
13.

Participation Rates With Opt-out Enrollment in a Remote Monitoring Intervention for Patients With Myocardial Infarction.

Mehta SJ, Troxel AB, Marcus N, Jameson C, Taylor D, Asch DA, Volpp KG.

JAMA Cardiol. 2016 Oct 1;1(7):847-848. doi: 10.1001/jamacardio.2016.2374. No abstract available.

PMID:
27603755
14.

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.

El-Shater Bosaily A, Valerio M, Hu Y, Freeman A, Jameson C, Brown L, Kaplan R, Hindley RG, Barratt D, Emberton M, Ahmed HU.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):322. doi: 10.1038/pcan.2016.37. Epub 2016 Aug 9. No abstract available.

15.

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.

El-Shater Bosaily A, Valerio M, Hu Y, Freeman A, Jameson C, Brown L, Kaplan R, Hindley RG, Barratt D, Emberton M, Ahmed HU.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):258-63. doi: 10.1038/pcan.2016.7. Epub 2016 Jul 12. Erratum in: Prostate Cancer Prostatic Dis. 2016 Sep;19(3):322.

16.

Simulated Permeation and Characterization of PEGylated Gold Nanoparticles in a Lipid Bilayer System.

Oroskar PA, Jameson CJ, Murad S.

Langmuir. 2016 Aug 2;32(30):7541-55. doi: 10.1021/acs.langmuir.6b01740. Epub 2016 Jul 21.

PMID:
27399834
17.

CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.

Feber A, Worth DC, Chakravarthy A, de Winter P, Shah K, Arya M, Saqib M, Nigam R, Malone PR, Tan WS, Rodney S, Freeman A, Jameson C, Wilson GA, Powles T, Beck S, Fenton T, Sharp TV, Muneer A, Kelly JD.

Cancer Res. 2016 Aug 15;76(16):4720-4727. doi: 10.1158/0008-5472.CAN-15-3134. Epub 2016 Jun 20.

18.

Transperineal Magnetic Resonance Imaging-targeted Biopsy versus Transperineal Template Prostate Mapping Biopsy in the Detection of Localised Radio-recurrent Prostate Cancer.

Kanthabalan A, Abd-Alazeez M, Arya M, Allen C, Freeman A, Jameson C, Kirkham A, Mitra AV, Payne H, Punwani S, Ramachandran N, Walkden M, Emberton M, Ahmed HU.

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):568-76. doi: 10.1016/j.clon.2016.04.038. Epub 2016 Jun 16.

PMID:
27318423
19.

Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review.

Whiting PF, Moore TH, Jameson CM, Davies P, Rowlands MA, Burke M, Beynon R, Savovic J, Donovan JL.

BJU Int. 2016 Aug;118(2):193-204. doi: 10.1111/bju.13499. Epub 2016 May 13. Review.

20.

Overcoming "I'll Think About It." Handling Objections.

Jameson C.

J Indiana Dent Assoc. 2016 Spring;95(2):34-7. No abstract available.

PMID:
29232082

Supplemental Content

Loading ...
Support Center